89 results
8-K/A
EX-99.1
ATOS
Atossa Therapeutics Inc
1 Apr 24
Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update
7:18pm
of major categories within R&D expense for the years ended December 31, 2023 and 2022, together with the dollar change in those categories … trials
Compensation
Professional fees and other
Research and Development Expense Total
R&D Expenses. R&D expenses for the year ended December 31, 2023
8-K
EX-99.1
ATOS
Atossa Therapeutics Inc
1 Apr 24
Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update
4:00pm
categories within R&D expense for the years ended December 31, 2023 and 2022, together with the dollar change in those categories (in thousands):
Year …
Compensation
Professional fees and other
Research and Development Expense Total
R&D Expenses. R&D expenses for the year ended December 31, 2023, were $17.3
8-K
EX-99.1
ATOS
Atossa Therapeutics Inc
13 Nov 23
Atossa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update
9:00am
and Development (R&D) and General and Administrative (G&A) expenses for the three months ended September 30, 2023 and 2022, together with the dollar … September 30, 2023 are explained below.
Research and Development Expenses: R&D expenses for the three months ended September 30, 2023 were $4,467
8-K
EX-99.1
ycj50j4t
14 Aug 23
Atossa Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
8:30am
8-K
EX-99.1
vu0myod5x41e5lgtj
15 May 23
Atossa Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update
9:10am
8-K
EX-99.1
ip6kz4yl
7 Nov 22
Atossa Therapeutics Announces Third Quarter 2022 Financial Results and Provides Corporate Update
4:00pm
8-K
EX-99.1
s235nm
8 Aug 22
Atossa Therapeutics Announces Second Quarter 2022 Financial Results and Provides Corporate Update
4:00pm
8-K
EX-99.1
i472x2ab6ay 5ell0
9 May 22
Atossa Therapeutics Announces First Quarter 2022 Financial Results and Provides Corporate Update
4:00pm
8-K
EX-99.1
t6qirb56amw8h
15 Nov 21
Atossa Therapeutics Announces Third Quarter 2021 Financial Results and Provides Corporate Update
9:25am
8-K
EX-99.1
qi6cns5u ztcn57s
13 Aug 21
Atossa Therapeutics Announces Second Quarter 2021 Financial Results - Provides Corporate Update and Information about Upcoming Stockholder Meeting
9:30am